Cantor Fitzgerald reiterates Overweight on Upexi stock at $2 target

Cantor Fitzgerald has renewed its Overweight rating on Upexi Inc. (NASDAQ:UPXI) and set a $2.00 price target, indicating strong potential for the stock. Currently trading at $1.05, this represents an 90% upside from the analyst’s target. However, shares have dropped 84.5% over the past year. During the latest quarter, Upexi earned 34,948 SOL from staking activities, amounting to $2.7 million.

This figure fell short of the projected $4.7 million and declined 23% quarter-over-quarter from $3.5 million in the third quarter of 2026. The decrease was primarily due to price rather than yield, as the staking revenue tracked a 6.5% annualized yield, aligning with Cantor Fitzgerald's expectations. The realized price of $77.13 was 38% below their assumption of $123.69.

Consumer brands revenue fell 57% quarter-over-quarter to $0.5 million, while total revenue reached $3.1 million, compared to the $5.8 million estimate. Gross profit of $3.0 million equated to a 96% gross margin, with the company's gross profit margin over the last year aligning with an InvestingPro Tip highlighting its impressive profitability metrics.

However, the platform notes that Upexi is rapidly depleting its cash reserves. The company's cost base is improving, interest burdens are decreasing, and the treasury remains intact at 2.34 million SOL. Upexi's fiscal fourth-quarter results exceeded expectations, with an adjusted loss of $0.11 per share, narrower than the $0.19 loss projected by analysts.

Revenue for the quarter was $5.8 million, substantially surpassing the forecasted $1.0 million. Despite these positive outcomes, Upexi's stock declined 2.37% in after-hours trading. The better-than-expected results in both earnings per share and revenue have garnered significant investor interest in Upexi's strategies and market sensitivities, particularly as the company marks its one-year anniversary of its Solana treasury strategy.